Literature DB >> 27719877

Transcranial magnetic stimulation and sedation as treatment for functional neurologic disorders.

T R J Nicholson1, V Voon2.   

Abstract

Functional neurologic disorder (FND), also known as conversion disorder, is common and often associated with a poor prognosis. It has been relatively neglected by research and as such there is a conspicuous lack of evidence-based treatments. Physical and psychologic therapies are the main treatment modalities, over and above reassurance and sensitive explanation of the diagnosis. However there are two other historic treatments that have seen a recent resurgence of interest and use. The first is electric stimulation, which was initially pioneered with direct stimulation of nerves but now used indirectly (and therefore noninvasively) in the form of transcranial magnetic stimulation (TMS). The second is (therapeutic) sedation, previously known as "abreaction," where it was mostly used in the context of psychologic investigation and treatment, but now increasingly advocated during rehabilitation as a way to therapeutically demonstrate reversibility of symptoms. This chapter introduces the background of these treatment modalities, their evolution into their current applications before critically evaluating their current evidence base and exploring possible mechanisms of action. It also tentatively suggests when they should be considered in current practice and briefly considers their future potential. In summary there is encouraging preliminary evidence to suggest that both TMS and sedation may be effective treatments for FNDs.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (transcranial) magnetic stimulation; TMS; abreaction; amytal; conversion disorder; dissociation; functional neurologic symptoms; hysteria; narcoanalysis; psychogenic; sedation

Mesh:

Substances:

Year:  2016        PMID: 27719877     DOI: 10.1016/B978-0-12-801772-2.00050-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

1.  Neurostimulation for Functional Neurological Disorder: Evaluating Longitudinal Neurophysiology.

Authors:  Matthew J Burke; Reina Isayama; Gaayathiri Jegatheeswaran; Carolyn Gunraj; Anthony Feinstein; Anthony E Lang; Robert Chen
Journal:  Mov Disord Clin Pract       Date:  2018-10-01

Review 2.  [Clinical and cognitive aspects of functional (psychogenic) tremor].

Authors:  K E Zeuner; R Schmidt; P Schwingenschuh
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 3.  Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports.

Authors:  Benjamin Stewart; Jon G Dean; Adriana Koek; Jason Chua; Rafael Wabl; Kayla Martin; Naveed Davoodian; Christopher Becker; Mai Himedan; Amanda Kim; Roger Albin; Kelvin L Chou; Vikas Kotagal
Journal:  Pharmacol Res Perspect       Date:  2020-12

4.  Functional MRI-based study of emotional experience in patients with psychogenic non-epileptic seizures: Protocol for an observational case-control study-EMOCRISES study.

Authors:  Pierre Fauvé; Louise Tyvaert; Cyril Husson; Emmanuelle Hologne; Xiaoqing Gao; Louis Maillard; Raymund Schwan; Claire Banasiak; Wissam El-Hage; Gabriela Hossu; Coraline Hingray
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

5.  Transcranial and muscular single-pulse magnetic stimulation is efficient on motor functional neurological disorders by the feedback of induced muscle contractions - A retrospective case series.

Authors:  Mickael Bonnan
Journal:  Clin Park Relat Disord       Date:  2021-10-20

6.  Impact of Transcranial Magnetic Stimulation on Functional Movement Disorders: Cortical Modulation or a Behavioral Effect?

Authors:  Béatrice Garcin; Francine Mesrati; Cécile Hubsch; Thomas Mauras; Iulia Iliescu; Lionel Naccache; Marie Vidailhet; Emmanuel Roze; Bertrand Degos
Journal:  Front Neurol       Date:  2017-07-19       Impact factor: 4.003

Review 7.  Neurostimulation for the treatment of functional neurological disorder: A systematic review.

Authors:  Irene Gonsalvez; Primavera Spagnolo; Barbara Dworetzky; Gaston Baslet
Journal:  Epilepsy Behav Rep       Date:  2021-11-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.